Definitive Contract 75N95024C00030
Award Date
9/16/24
Potential Completion Date
9/15/25
Potential Value
$306K
Federal Agency
National Institute on Drug Abuse
Awardee
Giner Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Auburndale, MA 02466, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
5
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $299,966.00 firm fixed-price SBIR Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Giner Inc., a small business research and development firm based in Boston. The contract is for the development of point-of-care monitoring technologies to assess adherence to antiretroviral HIV therapy. The original contract opportunity was part of a broader SBIR solicitation from the National Institutes of Health (NIH) and Centers for Disease Control...
This federal contract award is for a $299,999 Small Business Innovation Research (SBIR) Phase 1 contract issued by the National Institute of Mental Health (NIMH), which is part of the National Institutes of Health (NIH). The contract was awarded to Vitruvian Bio, LLC, a small, woman-owned, and disadvantaged business, to develop point-of-care assays for measuring HIV viral load and drug adherence. This contract is part of the NIH and Centers for Disease Control and Prevention (CDC) SBIR...
This is a $299,633 Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Giner Inc., a Boston-based research and development firm. The contract is for the development of a "smartphone-integrated point-of-care sensor for rapid and sensitive detection of malaria in low-resource applications." Giner Inc. has experience delivering technology...
This is a Small Business Innovation Research (SBIR) Phase I study contract awarded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a Civilian federal agency, to Giner Inc., a Boston-based research and development firm. The contract is for the development of a continuous monitoring system using wearable biosensors to track alcohol use. The contract has a ceiling value of $2,499,714.00 and includes an option for a Phase II study. Giner Inc. is a Subchapter S Corporation that has...
This is a $299,976.31 Firm Fixed Price definitive contract awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), to Guild Associates Inc. (doing business as Guild Biosciences), a small business manufacturer. The contract is for the development of point-of-care HIV viral load and drug adherence assays under the NIH's Small Business Innovation Research (SBIR) program. This work was solicited under SBIR Topic 001 of the anticipated PHS-2024-1...
This contract is an SBIR Phase I award from the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Giner Inc., a Boston-based research and development firm. The contract, valued at $149,983.00, is for a Small Business Innovation Research (SBIR) project and does not have a set-aside designation. Giner Inc. is a for-profit, subchapter S corporation that specializes in developing cutting-edge electrochemical technologies, including those for clean energy,...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $299,979.00 firm fixed-price definitive contract to Giner Inc., a small business, for the development of a rapid, point-of-care sensor for the detection of Hepatitis C virus infections. The contract has a completion date of May 31, 2023. Giner Inc. is a research and development firm based in Auburndale, Massachusetts that specializes in developing cutting-edge...
This is a $149,988.00 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Giner Inc., a Boston-based research and development firm. The contract is for the development of a "Rapid Touch Alcohol Sensor System" from July 1, 2008 to December 31, 2008, with a final completion date of March 31, 2010. Giner Inc. is a small business that has received numerous federal contracts...
This is a $222,608 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI) to Giner Inc., a Boston-based research and development firm. The contract is for the "Development of a pO2 Guided Core Needle Tumor Biopsy Device" under SBIR Topic 331. Giner Inc. is a for-profit, Subchapter S Corporation that has extensive experience delivering research, prototypes, and products to federal agencies like NASA, the Department of Defense, and the...
This is a $1,099,888.52 Firm Fixed Price definitive contract awarded by the Defense Health Agency (DHA) to Giner Inc., a Boston-based research and development firm focused on electrochemical technologies. The contract is for a STTR Phase II effort titled "Rapid and Reprogrammable Assay for Multiplexed Gene Detection." This Small Business set-aside contract supports the DHA's medical research and development mission, with an ultimate completion date of November 13, 2025. Giner Inc....